Comparing family members' motivations and attitudes towards genetic testing for hereditary breast and ovarian cancer: a qualitative analysis.

First-trimester screening for chromosomal abnormalities: advantages of an instant results approach.

Salivary testing for periodontal disease diagnosis and treatment.

Ripples from a stone skipping across the lake: a narrative approach to the meaning of Huntington's disease.

[BRCA1- and BRCA2 mutations: Clinical management of patients with hereditary breast and ovarian cancer]

Bio-banking and genetic testing: a comparison between European countries and India.

Impact of gene patents and licensing practices on access to genetic testing and carrier screening for Tay-Sachs and Canavan disease.

Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial.

Patient responses to genetic information: studies of patients with hereditary cancer syndromes identify issues for use of genetic testing in nephrology practice.

Improvement in the care of multiple endocrine neoplasia type 1 through a regional multidisciplinary clinic.

Women's experiences with genomic testing for breast cancer recurrence risk.

Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions of patients.

"I know what you told me, but this is what I think:" perceived risk of Alzheimer disease among individuals who accurately recall their genetics-based risk estimate.

Evaluation, diagnosis, and treatment of gastrointestinal disorders in individuals with ASDs: a consensus report.

B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.

[Care continuity for patients with Prader-Willi syndrome during transition from childhood to adulthood]

Disclosing the disclosure: factors associated with communicating the results of genetic susceptibility testing for Alzheimer's disease.

Personal genome testing: do you know what you are buying?

Social networkers' attitudes toward direct-to-consumer personal genome testing.

Breast cancer prevention: patient decision making and risk communication in the high risk setting.

Tumour tissue: who is in control?

Genetic counseling and the advanced practice oncology nursing role in a hereditary cancer prevention clinic: hereditary breast cancer focus (part I).

Scalp fibroblasts have a shared expression profile in monogenic craniosynostosis.

Barriers to the use of genetic testing: a study of racial and ethnic disparities.

[Drawing up guidelines for the attendance of physical health of patients with severe mental illness]